TE_11699
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | LINC01339, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 192.17 |
| Counts of samples | TCGA_tumor:340; TCGA_normal:0; GTEx:1 |
| TSS | chr5(-):90208734 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_11699.11 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90153324,90153344,90200467,90200528,90208304,90208735 |
| teRNA_11699.12 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90158499,90158519,90160529,90160589,90200467,90200528,90208304,90208735 |
| teRNA_11699.13 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90160569,90160589,90200467,90200528,90208304,90208735 |
| teRNA_11699.14 | - | Intergenic | Non-coding | Non-coding | chr5(-):90102214,90102234,90208304,90208735 |
| teRNA_11699.15 | - | Intergenic | Non-coding | Non-coding | chr5(-):90058031,90058051,90069405,90069526,90102166,90102234,90208304,90208735 |
| teRNA_11699.16 | - | Intergenic | Non-coding | Non-coding | chr5(-):90069506,90069526,90102166,90102234,90208304,90208735 |
| teRNA_11699.17 | - | Intergenic | Non-coding | Non-coding | chr5(-):90189899,90189919,90208304,90208735 |
| teRNA_11699.18 | LINC01339 | Chimeric | Non-coding | Non-coding | chr5(-):90158499,90158519,90160529,90160653,90208304,90208735 |
| teRNA_11699.19 | - | Intergenic | Non-coding | Non-coding | chr5(-):89839357,89839377,89839488,89839610,89908952,89909089,89932006,89932089,89943385,89943425,90208304,90208735 |
| teRNA_11699.20 | - | Intergenic | Non-coding | Non-coding | chr5(-):89865179,89865199,89908952,89909089,89932006,89932089,89943385,89943425,90208304,90208735 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
